Hhr Asset Management, LLC Voyager Therapeutics, Inc. Transaction History

Hhr Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.61 - $9.04 $287,304 - $563,390	-62,322 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$7.15 - $12.28 $154,411 - $265,198	-21,596 Reduced 25.73%	62,322 $446,000
Q3 2020 Nov 16, 2020	SELL	$10.01 - $13.75 $47,847 - $65,725	-4,780 Reduced 5.39%	83,918 $896,000
Q2 2020 Aug 07, 2020	SELL	$8.05 - $14.21 $118,093 - $208,460	-14,670 Reduced 14.19%	88,698 $1.12 Million
Q4 2019 Feb 14, 2020	SELL	$12.82 - $16.85 $132,430 - $174,060	-10,330 Reduced 9.09%	103,368 $1.44 Million
Q2 2019 Aug 14, 2019	BUY	$19.18 - $27.88 $2.18 Million - $3.17 Million	113,698 New	113,698 $3.1 Million

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $206M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Hhr Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hhr Asset Management, LLC with notifications on news.